急性呼吸窘迫综合征（ARDS）患者动脉血氧分压/吸入氧浓度比值（PaO?/FiO?）及柏林评分对越南地区住院预后的预测能力有限 ...

本研究通过回顾性多中心分析发现，衰弱患者急性呼吸窘迫综合征（AHRF）高发，且AHRF严重程度与衰弱程度均显著增加住院死亡率，呈现非线性关联。 尽管针对急性低氧血症性呼吸衰竭（AHRF）的重症患者的研究正在增加，但这种状况与患者虚弱状态之间的相互 ...

Acute respiratory distress syndrome is a significant complication in critical care patients. COVID-19 (C19)-associated severe respiratory failure is related to it, and d-dimer rise predicts a worse ...

The following is a summary of “Clinical Performance of Spo 2 /Fio 2 and Pao 2 /Fio 2 Ratio in Mechanically Ventilated Acute Respiratory Distress Syndrome Patients: A Retrospective Study,” published in ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

The following is a summary of “Prognostic value of PaO2/FiO2 ratio in predicting clinical outcomes in COVID-19 patients,” published in the June 2024 issue of Critical Care by Canto-Costal et al.

The models use maximal deflection of esophageal pressure to quantify HFOT-related breathing effort (ΔPes) and the risk for strong breathing effort (ΔPes >10 cmH2O). Two models have been developed to ...

ABSTRACT: Background: Recombinant human soluble thrombomodulin (rhTM) was approved for the treatment of disseminated intravascular coagulation in Japan, and rhTM has anti-inflammatory effects.

The PF ratio (PaO2/FiO2 ratio) is an essential indicator used in medicine to gauge the severity of a patient’s hypoxemic respiratory failure. This value helps healthcare professionals determine ...

The P/F ratio, also known as the PaO2/FiO2 ratio, is a valuable tool for evaluating oxygenation status in critically ill patients. It is commonly used to determine the severity of acute respiratory ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The performance of prognostic models for COVID-19 is ...